Prostate Cancer

Optimal MRI sequence for predicting extraprostatic extension in prostate cancer: comparison of LCC and MaxRADD measurements. June 26, 2026

Integrative genomic profiling of newly diagnosed prostate cancers progressing on surveillance. June 26, 2026

Incidence and Short- to Intermediate-Term Oncological Outcomes of Pathological T0 Prostate Cancer After Robot-Assisted Radical Prostatectomy: A Multicenter, Retrospective Cohort Study in Japan (MSUG94 Group). June 26, 2026

Quantifying the Renal Impact of [177Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry - Beyond the Abstract June 25, 2026

Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity. June 25, 2026

A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular Imaging. June 25, 2026

Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up. June 24, 2026

Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice. June 24, 2026

Testosterone Therapy After Radical Prostatectomy: Insights From a Systematic Review and Meta-Analysis. June 24, 2026

Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancer. June 24, 2026

The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients with Prostate Cancer on Active Surveillance. June 26, 2026

Development and validation of a multimodal artificial intelligence-based model for predicting post-prostatectomy treatment outcomes from baseline biparametric prostate magnetic resonance imaging. June 26, 2026

Post-diagnosis physical activity in relation to mortality among prostate cancer survivors: a systematic review and meta-analysis. June 26, 2026

PANDA-PLUS: Improved Dataset of Prostate Whole Slide Images from PANDA Challenge with Pixel-Level Expert Annotations - Beyond the Abstract June 25, 2026

How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management? June 25, 2026

Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer. June 25, 2026

Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA Profiling. June 24, 2026

Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol. June 24, 2026

Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study. June 24, 2026

NeuroSAFE-Guided Robot-Assisted Radical Prostatectomy versus Standard RARP: Systematic Review and Meta-Analysis of Comparative Studies - Beyond the Abstract June 23, 2026

Page 1 of 1640